The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 09, 2018

Filed:

May. 15, 2013
Applicant:

University of Southern California, Los Angeles, CA (US);

Inventors:

Michael Kahn, Altadena, CA (US);

Jia-Ling Teo, Altadena, CA (US);

Michael McMillan, Alhambra, CA (US);

Yi Zhao, South Pasadena, CA (US);

Yongfeng Wu, San Gabriel, CA (US);

Assignee:

University of Southern California, Los Angeles, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 38/50 (2006.01); C07D 487/04 (2006.01); A61K 31/4375 (2006.01); A61K 31/167 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/5575 (2006.01); A61K 31/58 (2006.01); A61K 45/06 (2006.01); A61K 31/573 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/167 (2013.01); A61K 31/4375 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/5575 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 38/50 (2013.01); A61K 45/06 (2013.01); C07D 487/04 (2013.01);
Abstract

Provided are: methods for treating aging or an age-related condition, symptom or disease; methods for stimulating hair growth, regrowth or pigmentation (or preventing hair loss); methods for increasing the expression of an adenosine receptor in dermal cells (in combination with hair growth); methods for treating a condition or disease of the skin or at least one symptom thereof, including cosmetic treatment (e.g., wrinkles, hyperpigmentation, redness, rosacea, dryness, cracking, loss of firmness, loss of elasticity, thinning, and loss of vibrance). The methods comprise administering a sufficient amount of a CBP/catenin (e.g., CBP/β-catenin) antagonist as disclosed, and particularly wherein administration is in an amount and manner sufficient to provide for increasing the number of asymmetric renewing divisions relative to, or at the expense of symmetric divisions in relevant somatic stem cell population. In particular aspects, the CBP/catenin (e.g., CBP/β-catenin) antagonist comprises an alkyl and/or fatty acid ester derivative thereof as disclosed herein.


Find Patent Forward Citations

Loading…